$ADTTF

ADVANTEST CORP

CIK:0001158838|SEC Filings

Consolidated Statements of Operations - JPY (¥) ¥ in Millions	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Net sales	¥ 163,329	¥ 111,878	¥ 132,903
Cost of sales	72,903	62,545	63,983
Gross profit	90,426	49,333	68,920
Research and development expenses	29,876	32,670	33,062
Selling, general and administrative expenses	45,720	39,964	35,778
Impairment charge	211	13,068
Operating income (loss)	14,619	(36,369)	80
Other income (expense):
Interest and dividend income	203	199	213
Interest expense	(137)	(140)	(132)
Gain on sale of investment securities	750	1,396	388
Impairment losses on investment securities			(400)
Other, net	3,424	(587)	(1,442)
Total other income (expense)	4,240	868	(1,373)
Income (loss) before income taxes and equity in earnings (loss) of affiliated company	18,859	(35,501)	(1,293)
Income tax expense	5,911	61	2,493
Equity in earnings (loss) of affiliated company		22	(35)
Net income (loss)	¥ 12,948	¥ (35,540)	¥ (3,821)
Net income (loss) per share:
Basic	¥ 74.31	¥ (204.10)	¥ (22.03)
Diluted	¥ 67.16	¥ (204.10)	¥ (22.03)

Consolidated Statements of Cash Flows - JPY (¥) ¥ in Millions	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income (loss)	¥ 12,948	¥ (35,540)	¥ (3,821)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	5,059	8,268	8,063
Deferred income taxes	2,063	(1,897)	693
Stock option compensation expense		1,283	861
Impairment losses on investment securities			400
Gain on sale of investment securities	(750)	(1,396)	(388)
Impairment charge	211	13,495
Changes in assets and liabilities, net of effect of acquisition:
Trade receivables	(1,690)	7,891	(1,004)
Inventories	(5,094)	2,806	(566)
Trade accounts payable	4,372	1,114	(6,475)
Accrued expenses	3,484	(1,376)	(4,529)
Income taxes payable	995	(424)	677
Accrued warranty expenses	(135)	(348)	(302)
Customer prepayments	2,342	(966)	611
Accrued pension and severance costs	1,328	998	841
Other	(652)	2,316	2,724
Net cash provided by (used in) operating activities	24,481	(3,776)	(2,215)
Cash flows from investing activities:
Proceeds from sale of available-for-sales securities	2,132	2,354	287
Acquisition of subsidiary, net of cash acquired		(1,273)
Proceeds from distribution of equity method investee		135
Purchases of property, plant and equipment	(3,230)	(5,511)	(11,386)
Purchases of intangible assets	(477)	(830)	(443)
Other	265	414	44
Net cash provided by (used in) investing activities	(1,310)	(4,711)	(11,498)
Cash flows from financing activities:
Decrease in short term debt			(25,000)
Proceeds from issuance of corporate bonds			25,000
Proceeds from issuance of convertible bonds		30,150
Dividends paid	(1,742)	(3,474)	(3,460)
Other	444	526	546
Net cash provided by (used in) financing activities	(1,298)	27,202	(2,914)
Net effect of exchange rate changes on cash and cash equivalents	6,704	4,614	4,077
Net change in cash and cash equivalents	28,577	23,329	(12,550)
Cash and cash equivalents at beginning of year	68,997	45,668	58,218
Cash and cash equivalents at end of year	97,574	68,997	45,668
Supplemental data:
Income taxes	1,486	2,711	1,519
Interest	¥ 137	¥ 140	¥ 87

Consolidated Balance Sheets - JPY (¥) ¥ in Millions	Mar. 31, 2015	Mar. 31, 2014
Current assets:
Cash and cash equivalents	¥ 97,574	¥ 68,997
Trade receivables, net	24,960	20,404
Inventories	37,210	30,200
Other current assets	5,057	5,218
Total current assets	164,801	124,819
Investment securities	2,249	3,741
Property, plant and equipment, net	38,480	39,925
Intangible assets, net	4,085	3,545
Goodwill	54,590	46,846
Other assets	8,836	10,980
Total assets	273,041	229,856
Current liabilities:
Trade accounts payable	18,101	12,353
Accrued expenses	10,482	6,775
Income taxes payable	2,106	1,089
Accrued warranty expenses	1,525	1,589
Corporate bonds - current portion	10,000
Customer prepayments	4,900	2,488
Other current liabilities	2,572	2,313
Total current liabilities	49,686	26,607
Corporate bonds	15,000	25,000
Convertible bonds	30,119	30,149
Accrued pension and severance costs	35,034	28,641
Other liabilities	2,264	3,207
Total liabilities	¥ 132,103	¥ 113,604
Commitments and contingent liabilities
Stockholders' equity:
Common stock, Authorized 440,000,000 shares; issued 199,566,770 shares	¥ 32,363	¥ 32,363
Capital surplus	43,770	43,906
Retained earnings	141,104	130,740
Accumulated other comprehensive income	18,387	5,326
Treasury stock, 25,368,828 shares in 2014 and 25,020,294 shares in 2015, at cost	(94,686)	(96,083)
Total stockholders' equity	140,938	116,252
Total liabilities and stockholders' equity	¥ 273,041	¥ 229,856